Brief: Terns Pharmaceuticals, Inc. posts Q2 basic EPS USD -0.25
08/08/2023 22:40
Aug 8 (Reuters) - Terns Pharmaceuticals, Inc. Q2 basic EPS USD -0.25. * Q2 net income USD -17.896 million * Q2 pretax profit USD -17.824 million * Q2 operating expenses USD 21.159 million * Q2 income from operations USD -21.159 million
Recent news on Terns Pharmaceuticals
See all newsNASDAQ TRADE HALT REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
U.S. RESEARCH ROUNDUP-East West Bancorp, Reliance, S&P Global
Brief: Merck Announces Expiration Of Hart-Scott-Rodino Act Waiting Period To Acquire Terns Pharmaceuticals
Brief: Merck Begins Tender Offer To Acquire Terns Pharmaceuticals, Inc.